Primary |
Product Used For Unknown Indication |
28.6% |
Anxiety |
9.5% |
Food Allergy |
9.5% |
Hypersensitivity |
9.5% |
Multiple Allergies |
9.5% |
Seasonal Allergy |
9.5% |
Allergic Rhinitis |
4.8% |
Asthma |
4.8% |
Rhinitis Allergic |
4.8% |
Sinusitis |
4.8% |
Urticaria |
4.8% |
|
Somnolence |
27.8% |
Exposure During Pregnancy |
11.1% |
Product Substitution Issue |
11.1% |
Chest Pain |
5.6% |
Oxygen Saturation Decreased |
5.6% |
Renal Pain |
5.6% |
Road Traffic Accident |
5.6% |
Sopor |
5.6% |
Suicidal Ideation |
5.6% |
Syncope |
5.6% |
Vision Blurred |
5.6% |
Weight Decreased |
5.6% |
|
Secondary |
Product Used For Unknown Indication |
34.5% |
Asthma |
10.5% |
Cough |
7.6% |
Drug Abuse |
7.0% |
Drug Use For Unknown Indication |
6.4% |
Angioedema |
5.8% |
Oropharyngeal Discomfort |
4.1% |
Depression |
3.5% |
Pharyngolaryngeal Discomfort |
3.5% |
Food Allergy |
2.9% |
Hypersensitivity |
2.3% |
Seasonal Allergy |
2.3% |
Osteoporosis |
1.8% |
Sinusitis |
1.8% |
Abdominal Discomfort |
1.2% |
Drug Rash With Eosinophilia And Systemic Symptoms |
1.2% |
Hepatic Neoplasm Malignant |
1.2% |
Prophylaxis Against Gastrointestinal Ulcer |
1.2% |
Age-related Macular Degeneration |
0.6% |
Atrial Fibrillation |
0.6% |
|
Pyrexia |
13.5% |
Completed Suicide |
8.1% |
Hepatitis Cholestatic |
8.1% |
Somnolence |
8.1% |
Urticaria |
8.1% |
Weight Decreased |
8.1% |
Drug Rash With Eosinophilia And Systemic Symptoms |
5.4% |
Swelling Face |
5.4% |
Torsade De Pointes |
5.4% |
Agranulocytosis |
2.7% |
Diarrhoea |
2.7% |
Hepatitis Fulminant |
2.7% |
Ischaemic Stroke |
2.7% |
Pain |
2.7% |
Pruritus |
2.7% |
Pruritus Generalised |
2.7% |
Rash Generalised |
2.7% |
Sopor |
2.7% |
Tongue Oedema |
2.7% |
Toxic Skin Eruption |
2.7% |
|
Concomitant |
Product Used For Unknown Indication |
15.9% |
Diabetes Mellitus |
9.8% |
Pruritus |
8.8% |
Asthma |
7.4% |
Pain |
6.8% |
Drug Use For Unknown Indication |
6.7% |
Constipation |
5.0% |
Rash |
4.6% |
Hypertension |
4.5% |
Hypersensitivity |
3.8% |
Depression |
3.2% |
Rheumatoid Arthritis |
3.2% |
Arthritis |
3.0% |
Prophylaxis |
2.9% |
Hepatitis C |
2.8% |
Gastrooesophageal Reflux Disease |
2.7% |
Insomnia |
2.6% |
Osteoporosis |
2.2% |
Neuropathy Peripheral |
2.1% |
Escherichia Sepsis |
2.0% |
|
Pyrexia |
8.0% |
Jaundice |
7.0% |
Pruritus |
7.0% |
Vomiting |
7.0% |
Skin Lesion |
6.0% |
Syncope |
6.0% |
Weight Increased |
6.0% |
Wrong Technique In Drug Usage Process |
6.0% |
Paraesthesia |
5.0% |
Serotonin Syndrome |
5.0% |
Skin Exfoliation |
5.0% |
Staphylococcal Sepsis |
5.0% |
Pulmonary Embolism |
4.0% |
Rash |
4.0% |
Toxicity To Various Agents |
4.0% |
Dizziness |
3.0% |
Off Label Use |
3.0% |
Oropharyngeal Pain |
3.0% |
Pain |
3.0% |
Rhinorrhoea |
3.0% |
|